论文部分内容阅读
目的:探讨阿奇霉素复合痰热清治疗小儿肺炎支原体肺炎的临床疗效。方法:收集我院2010年8月～2012年8月72例小儿肺炎支原体肺炎患儿,按照收住院日期(奇数、偶数)随机将其分为A、B 2组,A组设为对照组(阿奇霉素抗感染治疗+补液、营养支持等治疗),B组设为观察组(阿奇霉素抗感染治疗+痰热清+补液、营养支持等治疗),每组为36例。对2组患儿的临床症状和体征消失的时间、临床疗效进行观察、比较,对比统计分析。结果:观察组的总有效率为98.39%,对照组的总有效率为81.65%,2组比较差异具有统计学意义(p<0.05)。2组患儿的临床症状(发热、咳嗽)消失时间和体征(肺部啰音)消失时间比较差异具有统计学意义(p<0.05)。结论:阿奇霉素复合痰热清在治疗小儿肺炎支原体肺炎疗效确切、显著、起效快,可明显改善患儿的预后,值得在临床工作中推广应用。
Objective: To investigate the clinical efficacy of azithromycin combined with Tanreqing in treating Mycoplasma pneumoniae pneumonia in children. Methods: A total of 72 children with Mycoplasma pneumoniae pneumonia from August 2010 to August 2012 in our hospital were randomly divided into A and B 2 groups according to the date of hospital admission (odd and even), and the control group (A) Azithromycin anti-infective therapy + rehydration, nutritional support and other treatment), B group as the observation group (azithromycin anti-infective therapy + Tanreqing + rehydration, nutritional support and other treatment), 36 cases in each group. The clinical symptoms and signs of two groups of children disappeared time, clinical efficacy were observed, compared, comparative statistical analysis. Results: The total effective rate was 98.39% in the observation group and 81.65% in the control group. The difference between the two groups was statistically significant (p <0.05). There was a significant difference in the disappearance time of clinical symptoms (fever, cough) and signs (pulmonary rales) between the two groups (p <0.05). Conclusion: Azithromycin compound Tanreqing in the treatment of children with Mycoplasma pneumoniae pneumonia curative effect is exact, significant, rapid onset, can significantly improve the prognosis of children, it is worth to promote the clinical application.